Table S7. Five-year RFI assessed by AUC in multiple staging systems in training, internal validation, and external validation group.
| RFI | Training group | Internal validation group | External validation group | |||||||||||||
| AUC (95% CI) | Pa | Pb | Pc | AUC (95% CI) | Pa | Pb | Pc | AUC (95% CI) | Pa | Pb | Pc | |||||
| RFI, recurrence-free interval; AUC, area under the curve; CS, clinical stage; PS, pathologic stage. a, Contrast estimate with PS as reference; b, Contrast estimate with CPS+EG as reference; c, Contrast estimate with Neo-Bioscore as reference. | ||||||||||||||||
| CS | 0.629 (0.547−0.711) | 0.646 (0.551−0.742) | 0.563 (0.449−0.676) | |||||||||||||
| PS | 0.709 (0.638−0.779) | 0.711 (0.616−0.807) | 0.671 (0.556−0.786) | |||||||||||||
| CPS+EG | 0.688 (0.607−0.768) | 0.952 | 0.663 (0.566−0.760) | 0.014 | 0.656 (0.547−0.766) | 0.787 | ||||||||||
| Neo-Bioscore | 0.701 (0.622−0.780) | 0.998 | 0.624 | 0.737 (0.644−0.831) | 0.128 | 0.012 | 0.670 (0.561−0.779) | 0.984 | 0.480 | |||||||
| CPS+EGHlow | 0.760 (0.689−0.832) | 0.011 | 0.003 | 0.004 | 0.780 (0.701−0.858) | 0.024 | 0.030 | 0.254 | 0.701 (0.594−0.807) | 0.049 | 0.036 | 0.040 | ||||